DP08 Striking post COVID-19 vaccine aseptic pustular folliculitis, a follicular variant of acute generalized exanthematous pustulosis

Nikesh Patel,Natalie King-Stokes,Jonathan Carter,Richard Carr

DOI: https://doi.org/10.1093/bjd/ljae090.230

IF: 11.113

2024-06-28

British Journal of Dermatology

Abstract:Abstract This case report documents the unique presentation of a 46-year-old woman who developed a widespread follicular pustular rash, prominently affecting her face, neck, upper chest and back, merely 4 days after receiving the Pfizer–BioNTech COVID-19 vaccine. Laboratory investigations revealed an elevated neutrophil count of 10.6 × 109 L−1 and an increased C-reactive protein level of 96 mg L−1. A skin biopsy showed a striking neutrophilic pustular folliculitis, characterized by the absence of viral inclusions and the presence of neutrophil exocytosis in the adjacent epidermis. A diagnosis of a follicular pustular variant of acute generalized exanthematous pustulosis was proposed. In response to the diagnosis, the patient was initiated on a therapeutic regimen, including prednisolone at 30 mg and topical applications of clobetasol propionate for her body and fusidic acid–betamethasone valerate for her face. The treatment approach aimed at alleviating the inflammatory response associated with the neutrophilic infiltration observed in the skin biopsy. The patient exhibited a slow yet progressive improvement in her rash, which transitioned from a pustular to a nonpustular presentation. This case contributes to the growing body of evidence regarding cutaneous manifestations following COVID-19 vaccination. The association between the patient’s symptoms and the Pfizer–BioNTech vaccine suggests a potential link, emphasizing the importance of vigilance in monitoring adverse events postvaccination. While the specific mechanisms underlying such reactions remain unclear, the prompt initiation of corticosteroid therapy, as demonstrated in this case, appears effective in managing the inflammatory cutaneous manifestations. The patient’s positive response to treatment underscores the clinical significance of recognizing and promptly addressing these rare dermatological side-effects associated with COVID-19 vaccination. In conclusion, this case report sheds light on a distinctive presentation of neutrophilic pustular folliculitis following COVID-19 vaccination, highlighting the importance of dermatological vigilance in the ongoing global vaccination efforts. Further research is warranted to elucidate the underlying pathophysiological mechanisms and establish optimal management strategies for these rare cutaneous reactions.

dermatology